Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-11

Clinical Trial Update: Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing acetazolamide to diazepam in Landau-Kleffner Syndrome and electrographic status, terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)
  • Diazepam (Diazepam)

Snippet

Sponsor: Mayo Clinic | Conditions: Landau-Kleffner Syndrome, Status Epilepticus, Electrographic | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2020-06-11